Acquisition (Additional Information) (Details) - USD ($) $ in Thousands		3 Months Ended				6 Months Ended
		Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Business Acquisition [Line Items]
Recognized revenue	[1]	$ 49,999		$ 75,659		$ 110,863	$ 140,172
Net Income (Loss)		(75,270)	$ (104,624)	(66,065)	$ (89,532)	(179,894)	(155,597)
Class A Common Stock [Member]
Business Acquisition [Line Items]
Net Income (Loss)		$ (48,699)		$ (38,067)		$ (115,546)	$ (87,069)

[1] There was no Therapeutics revenue for the three and six months ended September 30, 2023 and 2022.